A Trial to Assess the Influence of a Pictorial Medication Calendar on Medication Taking Behaviour

NCT04701736 | Completed

• 1 other identifier: 107084
• Study Type: interventional
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

Determine if an oncology pictorial medication calendar will improve patient adherence to oncology supportive care medication regimens for adult patients receiving adjuvant or neo-adjuvant chemotherapy treatment for cancer.

Conditions

Cancer; Chemotherapy; Medication Adherence

Keywords

patient adherence; chemotherapy; pictorial aid; complex medication regimen; cancer

Outcome Measures

Primary Outcomes (1)

• Medication Adherence to Prescribed Antiemetics

  Adherence is quantified as the number of doses taken of a prescribed agent divided by the number of doses prescribed, expressed as a percentage. Pill counts were utilized to calculate the number of missed doses or pills taken as a percentage of the total number prescribed and dispensed.

  1 year

Secondary Outcomes (2)

• Patient Understanding and Satisfaction Survey

  1 year

• Medication Use and Self-Efficacy (MUSE) Scale

  1 year

Study Arms (2)

Routine Care

NO INTERVENTION

Routine care consists of an oncology pharmacist counselling the patient on supportive care medications prior to the patient getting his or her prescription dispensed.

Intervention

ACTIVE COMPARATOR

The intervention group will encompass the oncology pharmacist using the computer system to print a Picture Medication Calendar for the patient and use the calendar to explain supportive medications, in addition to routine care.

Device: Picture Medication Calendar

Interventions

Picture Medication Calendar DEVICE

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Outpatients 18 years or older receiving chemotherapy treatment for neoadjuvant or adjuvant solid organ cancers,
• Able to provide consent for themselves,
• Calendar was only available in the English language, thus fluency in English was required.

You may not qualify if:

• Participants who did not attain a minimum of grade 8 education,
• Significant visual impairment that precluded the ability to read the picture-based medication calendar,
• Difficulty swallowing with requirement for liquid formulations of medications,
• If planned to receive multiple cycles of chemotherapy at satellite oncology location instead of main study site,
• If unable to repeat the instructions back to research personnel or a care provider had to speak on the participant's behalf, the participant was withdrawn from the study.

Sponsors & Collaborators

• London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's: lead
• University of Waterloo: collaborator
• Medbuy Corporation: collaborator
• London Health Sciences Centre: collaborator

Study Sites (1)

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada

Location

MeSH Terms

Conditions

Neoplasms; Medication Adherence; Patient Compliance

Condition Hierarchy (Ancestors)

Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Venita Harris, PharmD

  London Health Sciences Centre

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 25, 2017
• First Posted: January 8, 2021
• Study Start: January 1, 2017
• Primary Completion: January 1, 2018
• Study Completion: January 1, 2018
• Last Updated: January 8, 2021

Record last verified: 2019-12

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)